These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5536480)

  • 21. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S; Barani R; Buzio C; Arisi L; Quaretti P
    Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guanidine succinate in acute and chronic uremia].
    Gróf J; Tankó A; Menyhárt J; Csata S
    Orv Hetil; 1974 Jan; 115(2):74-7. PubMed ID: 4839162
    [No Abstract]   [Full Text] [Related]  

  • 23. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 24. [A study of guanidine metabolism in uremia, with special reference to serum guanidinoacetic acid in anephric patients].
    Tofuku Y; Kuroda M; Muramoto H; Takeda R
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):171-81. PubMed ID: 6748335
    [No Abstract]   [Full Text] [Related]  

  • 25. Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle.
    Stein IM; Cohen BD; Kornhauser RS
    N Engl J Med; 1969 Apr; 280(17):926-30. PubMed ID: 5775630
    [No Abstract]   [Full Text] [Related]  

  • 26. Removal of waste metabolites in uremia by microencapsulated reactants.
    Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of methionine on the level of guanidinosuccinic acid in patients with uremia].
    Ksiazek A
    Pol Arch Med Wewn; 1977 Aug; 58(2):127-32. PubMed ID: 905158
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 29. Middle molecules in uraemia.
    Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
    Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
    [No Abstract]   [Full Text] [Related]  

  • 30. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prostaglandin metabolism in blood platelets and guanidine level in patients with chronic uremia].
    Komarnicki M; Pietrzak I; Zozulińska M; Czarnecki R; Antoniewicz K; Baczyk K
    Pol Arch Med Wewn; 1984 Nov; 72(5):243-7. PubMed ID: 6535143
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of rhubarb tannins on uremic toxins.
    Yokozawa T; Fujioka K; Oura H; Nonaka G; Nishioka I
    Nephron; 1991; 58(2):155-60. PubMed ID: 1865970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
    Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
    Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
    [No Abstract]   [Full Text] [Related]  

  • 34. Retention patterns.
    Schoots A; Vanholder R; Ringoir S; Cramers C
    Adv Exp Med Biol; 1987; 223():19-26. PubMed ID: 3447434
    [No Abstract]   [Full Text] [Related]  

  • 35. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
    Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
    Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning].
    Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB
    Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752
    [No Abstract]   [Full Text] [Related]  

  • 37. Dialysis of methylguanidine.
    Giovannetti S; Barsotti G
    Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of solute removal in hemodialysis.
    Gotch FA
    Adv Exp Med Biol; 1987; 223():227-37. PubMed ID: 3328954
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hyperprolactinemia and guanidinosuccinic acid in chronic renal failure].
    Fujimura A; Kawato M; Nakabayashi H; Tofuku Y; Noto M; Akiyama T; Kido C; Kuroda M; Takeda R
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):199-204. PubMed ID: 6620688
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous measurement of DTPA-clearance in extracorporeal detoxification circuits.
    Falkenhagen D; Ahrenholz P; Roy T; Esther G; Kiencke H; Klinkmann H
    Artif Organs; 1981; 4 Suppl():166-8. PubMed ID: 7295085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.